Adiantum
Adiantum, licence 80038221: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Adiante du Canada, Northern maidenhair
- Licence holder
- Thuja
- NPN or DIN-HM
- 80038221
- Status
- Active licence
- Licence date
- 12 December 2012
- Revision date
- Not provided
- Form
- Sachet de thé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Adiantum pedatum Source : Adiantum pedatum - En entier | 2.0 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Sachet de thé | minimum: 1.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Utilisé tradionnellement en phytothérapie en tant qu'émollient et astringent léger pour soulager les irritations des bronches et des poumons dans les cas de toux. Utilisé tradionnellement en phytothérapie en tant qu'émollient et astringent léger pour soulager les irritations bénignes du système urinaire.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soin de santé si les symptômes persistent ou s'aggravent. Cesser l'usage immédiatement en cas de nausées et/ou de vomissements.
- Effets indésirables connus
A fortes doses, peut provoquer de la nausée. Consulter un praticien de soins de santé avant d'en faire l'usage si vous souffrez de maladies gastro-intestinales.
- Contre-indications
Ne pas utiliser si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80038221
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.